Skip to main content

Research Repository

Advanced Search

The Na?/H? exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells

The Na?/H? exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells Thumbnail


Abstract

Dysregulation of Na?/H? exchanger isoform one (NHE1) activity is a hallmark of cells undergoing tumorigenesis and metastasis, the leading cause of patient mortality. The acidic tumor microenvironment is thought to facilitate the development of resistance to chemotherapy drugs and to promote extracellular matrix remodeling leading to metastasis. Here, we investigated NHE1 as a co-adjuvant target in paclitaxel chemotherapy of metastatic breast cancer. We generated a stable NHE1-knockout of the highly invasive, triple-negative, MDA-MB-231 breast cancer cells. The NHE1-knockout cells proliferated comparably to parental cells, but had markedly lower rates of migration and invasion in vitro. In vivo xenograft tumor growth in athymic nude mice was also dramatically decreased compared to parental MDA-MB-231 cells. Loss of NHE1 expression also increased the susceptibility of knockout cells to paclitaxel-mediated cell death. NHE1 inhibition, in combination with paclitaxel, resulted in a dramatic decrease in viability, and migratory and invasive potential of triple-negative breast cancer cells, but not in hormone receptor-positive, luminal MCF7 cells. Our data suggest that NHE1 is critical in triple-negative breast cancer metastasis, and its chemical inhibition boosts the efficacy of paclitaxel in vitro, highlighting NHE1 as a novel, potential co-adjuvant target in breast cancer chemotherapy.

Citation

(2014). The Na?/H? exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells. Oncotarget, 1262 - 1275. https://doi.org/10.18632/oncotarget.2860

Acceptance Date Nov 25, 2014
Publication Date Nov 26, 2014
Journal Oncotarget
Print ISSN 1949-2553
Publisher Impact Journals
Pages 1262 - 1275
DOI https://doi.org/10.18632/oncotarget.2860
Keywords NHE1, Paclitaxel, Triple-negative breast cancer, Metastasis, pH regulation
Publisher URL http://dx.doi.org/10.18632/oncotarget.2860

Files






Downloadable Citations